Mostrar el registro sencillo del ítem

Artículo

dc.creatorMartínez Ortega, Antonio Jesúses
dc.creatorFlores Martínez, Álvaroes
dc.creatorVenegas-Moreno, Evaes
dc.creatorDios, Elenaes
dc.creatorDel Can, Diegoes
dc.creatorRivas, Eloyes
dc.creatorSoto Moreno, Alfonso Manueles
dc.creatorCano, David A.es
dc.date.accessioned2022-09-27T17:33:09Z
dc.date.available2022-09-27T17:33:09Z
dc.date.issued2022
dc.identifier.citationMartínez Ortega, A., Flores Martínez, Á., Venegas-Moreno, E., Dios, E., Del Can, D., Rivas, E.,...,Cano, D.A. (2022). Sex Hormone Receptor Expression in Craniopharyngiomas and Association with Tumor Aggressiveness Characteristics. Journal of Clinical Medicine, 11 (1), 1-9.
dc.identifier.issn2077-0383es
dc.identifier.urihttps://hdl.handle.net/11441/137413
dc.description.abstractCraniopharyngiomas (CPs) are rare tumors of the sellar and suprasellar regions of embryonic origin. The primary treatment for CPs is surgery but it is often unsuccessful. Although CPs are considered benign tumors, they display a relatively high recurrence rate that might compromise quality of life. Previous studies have reported that CPs express sex hormone receptors, including estrogen and progesterone receptors. Here, we systematically analyzed estrogen receptor α (ERα) and progesterone receptor (PR) expression by immunohistochemistry in a well-characterized series of patients with CP (n = 41) and analyzed their potential association with tumor aggressiveness features. A substantial proportion of CPs displayed a marked expression of PR. However, most CPs expressed low levels of ERα. No major association between PR and ERα expression and clinical aggressiveness features was observed in CPs. Additionally, in our series, β-catenin accumulation was not related to tumor recurrence.es
dc.description.sponsorshipISCIII-Subdirección General de Evaluación y Fomento de la Investigación co-funded with Fondos FEDERes
dc.description.sponsorshipSistema Andaluz de Saludes
dc.formatapplication/pdfes
dc.format.extent9 p.es
dc.language.isoenges
dc.publisherMDPIes
dc.relation.ispartofJournal of Clinical Medicine, 11 (1), 1-9.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectCraniopharyngiomases
dc.subjectEstrogen receptores
dc.subjectProgesterone receptores
dc.subjectβ-catenines
dc.subjectImmunohisto-chemistryes
dc.titleSex Hormone Receptor Expression in Craniopharyngiomas and Association with Tumor Aggressiveness Characteristicses
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Medicinaes
dc.relation.projectIDPI16/00175 to A.S-M. and D.A.C.es
dc.relation.projectIDA-0006-2017 and A-0055-2018 to A.S-M, RC-0006-2018 to D.A.Ces
dc.relation.publisherversionhttps://www.mdpi.com/2077-0383/11/1/281/htmes
dc.identifier.doi10.3390/jcm11010281es
dc.journaltitleJournal of Clinical Medicinees
dc.publication.volumen11es
dc.publication.issue1es
dc.publication.initialPage1es
dc.publication.endPage9es

FicherosTamañoFormatoVerDescripción
Sex Hormone.pdf14.62MbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional